News

Bogota Financial Corp. Shows Strong Results as Earnings Rise

Bogota Financial Corp. Shows Strong Results as Earnings Rise

Bogota Financial Corp. Financial Update

In the latest financial announcement, Bogota Financial Corp. (NASDAQ: BSBK), the parent company of Bogota Savings Bank, released its financial results showcasing remarkable growth for the three months ended September 30, 2025. The company achieved a net income of $455,000, or $0.04 per share, reversing a loss of $367,000 during the same period last year. This upward trend is significant, indicating the company's resilience and recovery in a highly competitive banking environment.

Year-to-Date Performance Highlights

For the nine months concluding September 30, 2025, the company recorded a net income of $1.4 million, equating to $0.11 per share compared to a net loss of $1.2 million in the corresponding period of 2024. Notably, the nine-month results included a one-off gain from a life insurance policy amounting to approximately $543,000 related to a former employee. This one-time gain contributed significantly to the company’s improved profitability metrics.

Regulatory Approval for Share Buyback

In a strategic move, on August 12, 2025, Bogota Financial Corp. obtained regulatory clearance to repurchase up to 237,590 shares of its common stock, which constitutes about 5% of the outstanding shares. As of the date of the report, 4,821 shares had been repurchased at a total cost of $42,000, yet the repurchase program does not have a defined expiration date, allowing flexibility for management.

Asset and Liability Analysis

The total assets of Bogota Financial as of September 30, 2025, decreased by $45.7 million, or 4.7%, totaling approximately $925.8 million. This decline is attributed to a reduction in cash and cash equivalents and net loans, however, the securities portfolio increased by $20.4 million during the same timeframe, demonstrating an active approach to asset management amid fluctuating market conditions.

Loan Portfolio Adjustments

The company reported a decrease in net loans by $42.5 million, or 6.0%, with the total amount reaching $669.2 million. This reflects a decrease primarily in residential mortgages and construction loans, signaling a cautious stance on lending in light of current economic uncertainties. Conversely, deposits witnessed a marginal rise, with total deposits reaching $646.8 million, boosted by a boost in certificates of deposit.

Detailed Income Statement Observations

Notably, net interest income for the three months ended September 30, 2025, rose by $1.2 million to a total of $3.9 million, marking a significant 46.6% increase compared to the same period last year. This increase reflects an improving net interest margin, escalating to 1.80%, up from 1.15% a year prior, showcasing the effectiveness of the company's interest strategies.

Future Outlook

Kevin Pace, the President and CEO, expressed confidence in the company's direction. "Our third-quarter results reflect our continued resilience despite a challenging interest rate environment. Enhanced focus on commercial lending and sustaining quality customer relationships remains our primary aim as we look towards the future. As we commence the final quarter of 2025, the pursuit of operational efficiency and long-term value creation for our customers and shareholders will guide our strategies moving forward."

Frequently Asked Questions

1. What are the recent financial results for Bogota Financial Corp.?

Bogota Financial Corp. reported a net income of $455,000 for Q3 2025, rebounding from a net loss in the prior year.

2. How did the company's asset values change recently?

Total assets decreased by $45.7 million, primarily due to reductions in cash and loans.

3. What significant financial move was recently approved for Bogota Financial?

The company received regulatory approval for a share buyback plan, allowing repurchase of up to 237,590 shares.

4. How has the loan portfolio changed?

Net loans decreased by $42.5 million, reflecting a cautious approach in the competitive lending arena.

5. What is the outlook of the bank according to the CEO?

The CEO emphasized a focus on operational efficiency and long-term value for customers and shareholders moving forward.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 3

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 6

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 3

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 4

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 5

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 3

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 3

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 6

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 3

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 5

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Ties: Xi Jinping and Singaporean PM Wong Unite

Updated Category News Views 364

Strengthening Bilateral Relations for a Brighter Future In a significant meeting that highlights the growing ties between China and Singapore, President Xi Jinping recently welcomed Singaporean Prime Minister Lawrence Wong in Beijing. This engagement underscores the deepening friendship and collaboration between the two nations. During their discussions, President Xi...

Continue Reading
Revolutionizing 5G Processing with Ceva's Innovative Solutions

Updated Category News Views 283

Introduction to a New Era in 5G Technology As the world rapidly embraces the advancement of wireless communication, Ceva, Inc. (NASDAQ: CEVA) is spearheading a groundbreaking collaboration with Arm and SynaXG. This joint effort aims to significantly enhance energy efficiency in 5G New Radio (NR) processing, marking a major milestone for both terrestrial networks and Low...

Continue Reading
Alliance Trust PLC Announces Share Purchase Update

Updated Category News Views 113

Alliance Trust PLC Announces Share Purchase Alliance Trust PLC LEI: 213800SZZD4E2IOZ9W55 TRANSACTION IN OWN SHARES Recently, Alliance Trust PLC, known for its strategic investment approach, made a significant decision by acquiring 50,000 ordinary shares at a price of 1190.0p each. These shares will be held in Treasury, reflecting the company’s proactive strategy in...

Continue Reading
Lilabean Foundation and CBTN Unite for Pediatric Brain Cancer

Updated Category News Views 146

Advancing Pediatric Brain Cancer Research Together The Lilabean Foundation (LBF) is at the forefront of a significant movement to enhance pediatric brain cancer research through its innovative collaboration with the Children's Brain Tumor Network (CBTN). This partnership marks a transformative shift in how childhood brain tumors are treated and understood. Originally a...

Continue Reading
Eli Lilly's Breakthrough Drug EBGLYSS Offers Hope for Eczema

Updated Category News Views 351

A Promising Breakthrough for Eczema Sufferers Eli Lilly and Company (NYSE: LLY) has recently made headlines with the announcement of its innovative drug, EBGLYSS. This medication, functioning as an interleukin-13 (IL-13) inhibitor, has demonstrated substantial improvements in treating patients suffering from moderate-to-severe atopic dermatitis, particularly those who had...

Continue Reading